- Home
- Publications
- Publication Search
- Publication Details
Title
Disease-modifying treatments for progressive multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 19, Issue 11, Pages 1428-1436
Publisher
SAGE Publications
Online
2013-09-24
DOI
10.1177/1352458513502572
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic
- (2013) Sha Mi et al. CNS DRUGS
- Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair
- (2013) Jennifer Sabo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS
- (2013) Jeffrey A. Cohen et al. JOURNAL OF NEUROLOGY
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Cortical remyelination: A new target for repair therapies in multiple sclerosis
- (2012) Ansi Chang et al. ANNALS OF NEUROLOGY
- A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology
- (2012) James Kolasinski et al. BRAIN
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
- (2012) Peter Connick et al. LANCET NEUROLOGY
- Mesenchymal stem cells as treatment for MS – progress to date
- (2012) Antonio Uccelli et al. Multiple Sclerosis Journal
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Alemtuzumab more effective than interferon -1a at 5-year follow-up of CAMMS223 Clinical Trial
- (2012) A. J. Coles et al. NEUROLOGY
- Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials
- (2012) Rotem Orbach et al. PLoS One
- Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
- (2011) J D Bowen et al. BONE MARROW TRANSPLANTATION
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Regulation of remyelination in multiple sclerosis
- (2011) Khalid A. Hanafy et al. FEBS LETTERS
- Cannabinoid Treatment Renders Neurons Less Vulnerable Than Oligodendrocytes in Experimental Autoimmune Encephalomyelitis
- (2011) Henrik Hasseldam et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
- (2011) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
- (2011) Douglas S Goodin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Multiple sclerosis: more pieces of the immunological puzzle
- (2011) Ralf Gold et al. LANCET NEUROLOGY
- Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis
- (2011) J Theodore Phillips et al. Multiple Sclerosis Journal
- Long-term results of stem cell transplantation for MS: A single-center experience
- (2011) A. Fassas et al. NEUROLOGY
- Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
- (2011) V. Martinelli et al. NEUROLOGY
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
- (2010) Dimitrios Karussis et al. ARCHIVES OF NEUROLOGY
- Demyelination versus remyelination in progressive multiple sclerosis
- (2010) Stephan Bramow et al. BRAIN
- Lack of replication ofKIF1Bgene in an Italian primary progressive multiple sclerosis cohort
- (2010) F. Martinelli-Boneschi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
- (2010) Bassem Yamout et al. JOURNAL OF NEUROIMMUNOLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
- (2010) Mark S Freedman et al. Multiple Sclerosis Journal
- Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review
- (2010) James T Reston et al. Multiple Sclerosis Journal
- The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis
- (2010) Silvia Rossi et al. Multiple Sclerosis Journal
- Comparative study of mitoxantrone efficacy profile in patients with relapsing—remitting and secondary progressive multiple sclerosis
- (2010) Federica Esposito et al. Multiple Sclerosis Journal
- Stem cell transplantation in multiple sclerosis: current status and future prospects
- (2010) Gianvito Martino et al. Nature Reviews Neurology
- Widespread cortical thinning characterizes patients with MS with mild cognitive impairment
- (2010) M. Calabrese et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Glatiramer acetate treatment in PPMS: Why males appear to respond favorably
- (2009) Jerry S. Wolinsky et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
- (2009) X. Montalban et al. Multiple Sclerosis Journal
- Gray matter atrophy in multiple sclerosis: A longitudinal study
- (2008) Elizabeth Fisher et al. ANNALS OF NEUROLOGY
- Gray matter atrophy is related to long-term disability in multiple sclerosis
- (2008) Leonora K. Fisniku et al. ANNALS OF NEUROLOGY
- Axonal dysfunction in chronic multiple sclerosis: Meltdown in the membrane
- (2008) Stephen G. Waxman ANNALS OF NEUROLOGY
- LINGO-1 antagonists as therapy for multiple sclerosis:in vitroandin vivoevidence
- (2008) Richard A Rudick et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis
- (2008) Edgar Meinl et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Autologous haematopoietic stem-cell transplantation in multiple sclerosis
- (2008) Gianluigi Mancardi et al. LANCET NEUROLOGY
- Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis
- (2008) Marco Rovaris et al. Multiple Sclerosis Journal
- Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways
- (2008) J Sepulcre et al. Multiple Sclerosis Journal
- Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
- (2008) May H. Han et al. NATURE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinically isolated syndrome: the rationale for early treatment
- (2008) Giancarlo Comi Nature clinical practice. Neurology
- Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open-label comparative study of efficacy and safety
- (2007) Valentina Zipoli et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now